期刊文献+

血小板内皮细胞黏附分子的剪接体在胚胎干细胞血管形成过程中的表达 被引量:1

Expression of alternatively spliced isoforms of platelet endothelial cell adhesion molecule-1 of embryonic stem cells during vasculogenesis and angiogenesis
原文传递
导出
摘要 目的探讨血小板内皮细胞黏附分子(PECAM)1的剪接体在胚胎干细胞分化过程中的表达规律。方法体外培养胚胎干细胞,在细胞因子的作用下形成胚胎样小体(EB);然后将EB种植到胶原中,在细胞因子的作用下诱导出芽性血管新生。分别利用免疫组织化学、流式细胞术、逆转录聚合酶链反应等方法检测胚胎干细胞及其分化过程中PECAM1、Oct4及胚胎阶段特异性抗原(SSEA)1的表达。应用克隆分析的方法检测不同的PECAM1剪接体在EB形成和出芽性血管新生过程中的表达分布。结果PECAM1主要表达在胚胎干细胞细胞连结部位。随着胚胎干细胞的分化,Oct4及SSEA1表达下降。胚胎干细胞表达8种PECAM1的剪接体,包括全长、Δ12、Δ14、Δ15、Δ12&14、Δ12&15、Δ14&15、Δ12&14&15,其中Δ15和Δ14&15表达水平最高。在胚胎干细胞形成EB和出芽性血管新生过程中,剪接体表达水平发生变化,其中Δ12&14&15的表达明显上升,Δ15表达下降。结论未分化的胚胎干细胞表达PECAM1,剪接体的表达变化可能参与了胚胎干细胞的血管形成。 Objective To study the expression of alternatively spliced isoforms of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) of embryonic stem cells (ES cells) during vasculogenesis and angiogenesis. Methods Mouse ES cells of the line J1 were cultured. Another ES cells were cultured in differentiation medium to induce the formation of embryonic bodies (EBs). Then the ES cells with PECAM-1 and EBs were inoculated with methylcellulose into Petri dish, containing cell growth factor, VEGF, bFGF, EPO, and IL-6 and the ES cells cultured for 11 days were inoculated in the Petri dish with collagen for 72 hours so as to induce sprouting angiogenesis. Immunofluorescence analysis, RT-PCR, and flow cytometry were used to detect the expression of PECAM-1, Oct-4, and stage-specific embryonic antigen (SSEA)-1 in the undifferentiated ES cells, EBs, and EB sprouting. In order to delineate the alternatively spliced cytoplasmic domain isoforms of PECAM-1 specific primers were designed to span the exon-exon junctions in the regions of alternative splicing. In order to amplify the cytoplasmic domains of all possible PECAM-1 isoforms a sense primer spanning the border of exons 9 and 10 within the cytoplasmic domain and an antisense primer spanning the border of exon 16 and 3′-untranslated region were used. Then the PCR products of the cytoplasmic domain underwent subsequent sequencing to analyze the expression of the 8 known alternatively splice isoforms of PECAM-1. Results The ES cells expressed high level PECAM-1 that was mainly located at the cell-cell junctions. The SSEA-1 and Oct-4 levels rapidly decreased along with the differentiation of the ES cells. All 8 known alternatively splice isoforms of PECAM-1 were expressed in the ES cells and the EB sprouting, the expression of Δ14%15 and Δ12&14&15 being the highest. The expression level of Δ12&14&15 increased markedly and the expression of Δ15 decreased along with the differentiation of ES cells. Conclusion PECAM-1 is a constitutive feature of undifferentiated ES cells. Its changes in splice form mark the differentiation and may participate in vasculogenesis and angiogenesis.
出处 《中华医学杂志》 CAS CSCD 北大核心 2005年第19期1299-1304,共6页 National Medical Journal of China
基金 国家"863"高科技研究发展计划基金资助项目(2002AA217041 2003AA205060) 天津市自然科学基金重点资助项目(043607011)
关键词 血小板内皮细胞黏附分子 剪接体 胚胎干细胞 血管形成 表达 细胞培养 Stem cells Embryo Antigens, CD31 Spliceosomes
  • 相关文献

参考文献15

  • 1Keller GM. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol, 1995, 7:862-869.
  • 2DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today, 1994,15:490-495.
  • 3Hirashima M, Kataoka H, Nishikawa S, et al. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood, 1999, 93: 1253-1263.
  • 4Yin Y, Que J, Teh M, et al. Embryonic cell lines with endothelial potential: an in vitro system for studying endothelial differentiation. Arterioscler Thromb Vasc Biol, 2004, 24: 691-696.
  • 5Wang Z, Cohen K, Shao Y, et al. Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels. Blood, 2004,103: 100-109.
  • 6Kalberer CP, Antonchuk J, Humphries K. Hematopoietic stem cell protocols. In: Klug CA, Jordan CT, eds. Hematopoietic stem cell protocol, methods in molecular medicine. Totowa, NJ: Human Press Inc, 2000. 209-231.
  • 7李宗金,杨晨,汤锋武,张志华,徐斌,赵钦军,杨仁池,王征宇,韩忠朝.体外诱导小鼠胚胎干细胞血管形成[J].中国医学科学院学报,2005,27(1):62-66. 被引量:7
  • 8Wang Y, Su X, Sorenson CM, et al. Tissue-specific distributions of alternatively spliced human PECAM-1 isoforms. Am J Physiol Heart Circ Physiol, 2003, 284: H1008-1017.
  • 9Risau W. Mechanisms of angiogenesis. Nature, 1997, 386:671-674.
  • 10Carmeliet P. Angiogenesis in health and disease. Nat Med, 2003, 9:653-660.

二级参考文献23

  • 1Kalberer CP, Antonchuk J, Humphries K. Hematopoietic stem cell protocols. In: Klug CA, Jordan CT, eds. Methods in molecular medicine. Totowa, NJ: Human Press Inc,2002.209-231.
  • 2Vittet D, Prandini MH, Berthier R, et al. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood, 1996, 88(9):3424-3431.
  • 3Feraud O, Cao Y, Vittet D. Embryonic stem cell-derived embryoid bodies development in collagen gels recapitulates sprouting angiogenesis. Lab Invest, 2001, 81(12):1669-1681.
  • 4Haas TL, Davis SJ, Madri JA. Three-dimensional type Ⅰ collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem, 1998, 273(6):3604-3610.
  • 5D'Amato RJ, Loughnan MS, Flynn E, et al. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA,1994, 91(9):4082-4085.
  • 6Yoshida H, Kunisada T, Kusakabe M, et al. Distinct stages of melanocyte differentiation revealed by analysis of nonuniform pigmentation patterns. Development, 1996, 122(4):1207-1214.
  • 7Bunea M, Zarnescu O. New current aspects on the immunohistochemical techniques. Roum Biotechnol Lett, 2001, 6(3): 177-206.
  • 8Risau W. Mechanisms of angiogenesis. Nature, 1997, 386:671 - 674.
  • 9Carmeliet P. Angiogenesis in health and disease. Nat Med,2003, 9:653-660.
  • 10Vailhe B, Vittet D, Feige JJ. In vitro models of vasculogenesis and angiogenesis. Lab Invest, 2001, 81:439-452.

共引文献28

同被引文献9

  • 1D'Angio CT,Maniscalco WM.The role of vascular growth factors in hyperoxia-induced injury to the developing lung.Front Biosci,2002,59:1609-1623.
  • 2Bhatt A J,Pryhuber GS,Huyck H,et al.Disrupted pulmonary vaaculature and decreased vascular endothelial growth factor,Flt-1,and TIE-2 in human infants dying with bronchopulmonary dysplasia.Am J Respir Crit Care Med,2001,164:1971-1980.
  • 3Lassus P,Ristimaki A,Ylikorkala O,et al.Vascular endothelial growth factor in human preterm lung.Am J Respir Crit Care Med,1999,159:1429-1433.
  • 4Delisser HM,Newman PJ,Albelda SM.Molecular and functional aspects of PECAM-1/CD31.Immunol Today,1994,15:490-495.
  • 5Wenzel C,Kofler J,Locker GJ,et al.Endothelial cell activation and blood coagulation in critically ill patients with lung injury.Wien Klin Wochenschr,2002,114:853-858.
  • 6Thebaud B,Ladha F,Michelakis ED,et al.Vascular endothelial growth factor gene therapy increases survival,promotes lung angiogenesis,and prevents alveolar damage in hyperoxia-induced lung injury:evidence that angiogenesis participates in alveolarization.Circulation,2005,112:2477-2486.
  • 7Compernolle V,Brusselmans K,Acker T,et al.Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturarion,whereas treatment with VEGF prevents fatal respiratory distress in premature mice.Nat Med,2002,8:702-710.
  • 8Maniscalco WM,Watkins RH,Pryhuber GS,et al.Angiogenic factors and alveolar vasculature:development and alterations by injury in very premature baboons.Am J Physiol Lung Cell Mol Physiol,2002,282:L811-823.
  • 9李涛,肖玉,王宏伟,麦根荣,徐少勇,谢集建,李东升.血管内皮生长因子对肺表面活性物质磷脂合成的影响[J].中国新生儿科杂志,2007,22(5):285-288. 被引量:5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部